← Back to the page you were readingYou opened this term from another page.
IP · ProsecutionTask: Draft and prosecute

Patent term adjustment (PTA)

Also called PTA, A delay, B delay, C delay, patent term guarantee, USPTO delay adjustment

Published by Patsnap Team Updated 11 sources
DefinitionPTA

Patent term adjustment (PTA) is additional term given to a US patent when its issue is delayed by the USPTO missing statutory time limits, or by derivation proceedings, secrecy orders or successful appeals. Under 35 U.S.C. 154(b), the term is extended one day for each day of such delay, less any period in which the applicant failed to make reasonable efforts to conclude prosecution1.

The adjustment runs from the patent's normal expiration date3, which is 20 years from the US filing date or, where the application specifically refers to earlier applications under 35 U.S.C. 120, 121, 365(c) or 386(c), from the earliest such filing date1. The USPTO's PTA rules apply to original applications, other than design applications, filed on or after May 29, 20002.

AppliesUS original applications filed on or after May 29, 2000, except design applications2
Governed by35 U.S.C. 154(b) and 37 CFR 1.702 to 1.7051,2
Comes upAt issue: the patent states any adjustment the USPTO has determined5
Not to confuse withPatent term extension for regulatory review under 35 U.S.C. 1566
01

The three kinds of USPTO delay

Section 154(b)(1) sets out three guarantees, each of which extends the term one day per day of delay1. USPTO decisions label the resulting periods A delay, B delay and C delay8.

DelayWhat triggers itSource
A delayThe USPTO misses a set time limit: a first action or notice of allowance within 14 months of filing or national stage commencement; a response to a reply or appeal within 4 months; action within 4 months after a board or court decision where allowable claims remain; issue within 4 months after the issue fee is paid and all requirements are met135 U.S.C. 154(b)(1)(A); 37 CFR 1.702(a)1,2
B delayThe USPTO fails to issue the patent within 3 years of the actual filing date or national stage commencement, not counting time consumed by continued examination requested by the applicant, derivation proceedings, secrecy orders, appellate review, or processing delays the applicant requested135 U.S.C. 154(b)(1)(B); 37 CFR 1.702(b)1,2
C delayIssue is delayed by a derivation proceeding, a secrecy order, or appellate review that reversed an adverse determination of patentability135 U.S.C. 154(b)(1)(C); 37 CFR 1.702(c) to (e)1,2
02

How the adjustment is calculated

  1. Add up the delay periodsThe adjustment is the sum of the A, B and C delay periods calculated under 37 CFR 1.703(a) to (e), to the extent they do not overlap3.
  2. Count overlapping days onceWhere delay periods overlap, the adjustment cannot exceed the actual number of days the issue of the patent was delayed1.
  3. Subtract applicant delayThe adjustment is reduced by the time during which the applicant failed to engage in reasonable efforts to conclude prosecution1. Under USPTO rules this includes any time beyond three months taken to reply to a notice making a rejection, objection, argument or other request4.
  4. Apply any terminal disclaimerA patent whose term has been disclaimed beyond a specified date cannot be adjusted beyond the expiration date in the disclaimer1. In addition, the Federal Circuit held in In re Cellect (2023) that obviousness-type double patenting for a patent that has received PTA must be judged on its expiration date after PTA is added, whether or not a terminal disclaimer is required or has been filed10. See Double patenting.

USPTO decisions state the result as a formula: PTA equals A delay plus B delay plus C delay, minus overlap, minus applicant delay8.

Other conduct the rules treat as applicant delay includes abandoning the application or paying the issue fee late, filing a supplemental reply that the examiner did not request, and filing a request for continued examination after a notice of allowance4.

03

How PTA is determined and challenged

  • Determination. The USPTO determines the adjustment and must send notice of it no later than the date the patent issues1. The patent itself includes notification of any adjustment5.
  • Reconsideration. A request for reconsideration must be made by an application for patent term adjustment filed no later than two months from the date the patent was granted; this period may be extended under 37 CFR 1.136(a)5.
  • Reinstatement of a reduction. All or part of a reduction for replies filed after three months can be reinstated if the applicant shows that, in spite of all due care, it could not reply in time. The request must be filed before the patent issues, and no more than three additional months per reply can be reinstated1,5.
  • Court review. An applicant dissatisfied with the decision on reconsideration may bring a civil action against the Director in the US District Court for the Eastern District of Virginia within 180 days of that decision1.
  • Third parties. A PTA determination cannot be challenged by a third party before grant, and the USPTO does not consider third party submissions on PTA1,5.
04

Which patents can receive PTA

The current rules in 37 CFR 1.702 to 1.705 apply only to original applications, except design applications, filed on or after May 29, 2000, and to patents issued on them2. Section 154(b) was amended with effect from that date, and again by the Leahy-Smith America Invents Act in 2011 and the AIA Technical Corrections Act in 20137.

When prosecution continues through a continuing application, the adjustment does not include any period before the actual filing date of the application that resulted in the patent4.

China's Patent Law has a comparable rule. Where an invention patent is granted more than four years after the filing date and more than three years after the request for substantive examination, the term is extended at the patentee's request to compensate for unreasonable delay in granting it, except delay caused by the applicant (Article 42)9. The patentee must request it within three months of the announcement of grant (Implementing Regulations, Rule 77)11.

05

PTA vs patent term extension

Both lengthen a US patent's term, but for different reasons and under different statutes1,6.

Patent term adjustmentPatent term extension
Why it existsOffsets delays in issuing the patent caused by the USPTO, derivation proceedings, secrecy orders or successful appeals1Extends a patent claiming a product, or a method of using or making it, where the product was subject to a regulatory review period before its commercial marketing or use6
Statute35 U.S.C. 154(b)135 U.S.C. 1566
How it is obtainedDetermined by the USPTO, with notice no later than the issue date1The patent owner of record applies to the Director, within 60 days beginning on the date the product received permission for commercial marketing or use, with limited exceptions6
How they combineRuns from the expiration date set by 35 U.S.C. 154(a)(2)3Runs from the original expiration date, which includes any PTA6
LimitOverlapping delays count once, and applicant delay is subtracted1The extension cannot exceed five years, and if the term remaining after approval plus the qualifying regulatory review period exceeds 14 years, it is reduced so the total is 14 years6
06

Seen in the record

USPTO decisions on requests for reconsideration show the calculation in practice. The decision is shown for its calculation; it says nothing about the patentee beyond the record.

USPTO final agency decisionRequest for reconsideration of PTA

In re Patent of Ball et al., U.S. Patent No. 9,349,130

Patent 9,349,130Issued 24 May 2016PTA 878 daysPTA unchanged on reconsideration

The patent issued with a PTA of 878 days: 689 days of A delay plus 219 days of B delay plus 0 days of C delay, less 0 days of overlap and 30 days of applicant delay. The patentee argued B delay was 554 days and sought 1,213 days; the USPTO confirmed 878 days8.

Read how each delay period was counted.Open the record →
Patsnap EurekaEureka IP

Draft and prosecute

Patent Drafting AI Agent

An AI agent that drafts claims and a full specification from a disclosure, with a compliance review before you finish.

Start drafting
07

Questions people ask

Do I have to apply for patent term adjustment?

No. The USPTO determines the adjustment itself and must send notice of it no later than the date the patent issues1. A patentee who disagrees can file an application for patent term adjustment within two months of grant5.

What is the difference between PTA and patent term extension?

PTA offsets delays in issuing a patent, such as the USPTO missing statutory time limits, under 35 U.S.C. 154(b)1. Patent term extension under 35 U.S.C. 156 is for patents on products that went through a regulatory review period before commercial marketing or use, and it runs from an expiration date that already includes any PTA6.

Can a terminal disclaimer cancel PTA?

It can limit it. A patent whose term has been disclaimed beyond a specified date cannot be adjusted beyond the expiration date specified in the disclaimer1,3. In addition, the Federal Circuit held in In re Cellect (2023) that obviousness-type double patenting for a patent that has received PTA must be based on its expiration date after PTA is added, regardless of whether a terminal disclaimer is required or has been filed10. See Double patenting.

Does a continuation inherit PTA from its parent's prosecution?

No. Under 37 CFR 1.704(c)(14), the adjustment for a patent obtained through a continuing application does not include any period before that application's actual filing date4.

08

How it connects

Next step

Go from the term to the task

Read how the method works, run it on your own product or idea, then try a free tool.

  • 01 / How-toPatentability search: a practical guideCheck whether an invention is new before you spend on a filing.GuideRead
  • 02 / AI agentNovelty Search AI AgentAn AI agent that searches prior art for your invention and compares each reference with it feature by feature.Patsnap EurekaRun it
  • 03 / Free toolPatent draft style studioRewrite a technical description in claim language.AI resultTry tool
PublishedPatsnap Team
Updated 27 October 2026
Sources
  1. 35 U.S. Code § 154: Contents and term of patent; provisional rights. Legal Information Institute, Cornell Law School. Accessed 21 October 2026.
  2. 37 CFR 1.702: Grounds for adjustment of patent term due to examination delay under the Patent Term Guarantee Act of 1999. Electronic Code of Federal Regulations (eCFR). Accessed 21 October 2026.
  3. 37 CFR 1.703: Period of adjustment of patent term due to examination delay. Electronic Code of Federal Regulations (eCFR). Accessed 21 October 2026.
  4. 37 CFR 1.704: Reduction of period of adjustment of patent term. Electronic Code of Federal Regulations (eCFR). Accessed 21 October 2026.
  5. 37 CFR 1.705: Patent term adjustment determination. Electronic Code of Federal Regulations (eCFR). Accessed 21 October 2026.
  6. 35 U.S. Code § 156: Extension of patent term. Legal Information Institute, Cornell Law School. Accessed 21 October 2026.
  7. MPEP 2730: Applications Filed on or After May 29, 2000; Grounds for Adjustment. United States Patent and Trademark Office (USPTO). Accessed 21 October 2026.
  8. In re Patent of Ball et al., Patent No. 9,349,130: Final Agency Decision on Request for Reconsideration of Patent Term Adjustment. United States Patent and Trademark Office (USPTO), Office of Petitions. Accessed 21 October 2026.
  9. Patent Law of the People's Republic of China (amended up to October 17, 2020). WIPO Lex, World Intellectual Property Organization. Accessed 21 October 2026.
  10. In re Cellect, LLC, Nos. 2022-1293 to 2022-1296 (Fed. Cir. Aug. 28, 2023). United States Court of Appeals for the Federal Circuit. Accessed 27 October 2026.
  11. 中华人民共和国专利法实施细则(2023年修订) (Implementing Regulations of the Patent Law of the PRC, revised 2023). China National Intellectual Property Administration (CNIPA). Accessed 27 October 2026.
Disclaimer

General information only. This page explains a term for general information and reference only. It is not legal, accounting, tax or other professional advice and must not be relied upon as such. It does not create an attorney-client or other professional relationship.

Sources and accuracy. Statements on this page are intended to be either general background or linked to a source listed under Sources. The explanations summarize and simplify those sources and leave out detail. Where this page differs from a cited source or from the current official text of a law or standard, rely on that source or text. To the extent permitted by law, this page is provided as is, without any warranty that it is complete, accurate or current, and Patsnap accepts no liability for loss arising from reliance on it. See also Patsnap’s website Disclaimer.

Rules vary and change. The law, standards and practice described here differ between jurisdictions and change through legislation, court decisions and revisions to official guidance and standards. This page was last checked against its sources on 27 October 2026 and may not reflect later changes. Check the current rules and official guidance in each jurisdiction that applies to you.

No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.

Cases and records as examples. Court decisions, dockets, agency decisions and official reports are cited to show how a term is used, and are summarized rather than reproduced in full. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed, beyond what the cited record or decision itself states.

Third-party names, marks and links. Names of courts, government bodies, parties, people, companies, standards and products appear for identification only. Some of these names are trademarks of their owners; their appearance does not, by itself, imply affiliation with or endorsement by Patsnap. Links to third-party sources are provided for reference, and Patsnap is not responsible for their content or availability.

Patsnap Eureka. Patsnap publishes this glossary and also offers Patsnap Eureka, a commercial product mentioned on this page. Those mentions describe what its tools are designed to do, not what they will find in a particular case. Their outputs are research aids and should be reviewed by a qualified professional before being relied on.

Corrections and requests. If you believe a statement on this page is inaccurate or out of date, use “Share feedback” at the bottom of this page and tell us which statement and why. If you are named on this page, or your concern is about legal rights or personal information, email legal@patsnap.com. We review reports and may correct or update the page.

Patent Drafting AI AgentStart drafting in Patsnap EurekaStart →

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.